Recall of Paxil Products (2014-04-08) Apr 8, 2014 · Published by Health Canada · Official notice
Share
Alert type : Drug Recall
Category : Drugs
Issue : Product Safety
Audience : General Public, Healthcare Professionals, Hospitals
Department : Health Canada
Hazard classification : Type III
Lot or serial number Brand name Companies Dosage form DIN, NPN, DIN-HIM Strength 2ZP0326 D. Paxil Tablets 10 mg Recalling Firm GlaxoSmithKline Inc. 7333 Mississauga Road North Mississauga L5N 6L4 Ontario CANADA Marketing Authorization Holder GlaxoSmithKline Inc. 7333 Mississauga Road North Mississauga L5N 6L4 Ontario CANADA Tablets DIN 02027887 10 mg 2A001 B. Paxil CR 12.5 mg Recalling Firm GlaxoSmithKline Inc. 7333 Mississauga Road North Mississauga L5N 6L4 Ontario CANADA Marketing Authorization Holder GlaxoSmithKline Inc. 7333 Mississauga Road North Mississauga L5N 6L4 Ontario CANADA Controlled-Release Tablets DIN 02248503 12.5 mg 2ZP2644 C. Paxil Tablets 20 mg Recalling Firm GlaxoSmithKline Inc. 7333 Mississauga Road North Mississauga L5N 6L4 Ontario CANADA Marketing Authorization Holder GlaxoSmithKline Inc. 7333 Mississauga Road North Mississauga L5N 6L4 Ontario CANADA Tablets DIN 01940481 20 mg 2A001 A. Paxil CR 25 mg Recalling Firm GlaxoSmithKline Inc. 7333 Mississauga Road North Mississauga L5N 6L4 Ontario CANADA Marketing Authorization Holder GlaxoSmithKline Inc. 7333 Mississauga Road North Mississauga L5N 6L4 Ontario CANADA Controlled-Release Tablets DIN 02248504 25 mg
Recalled Products
A. Paxil CR 25 mg
B. Paxil CR 12.5 mg
C. Paxil Tablets 20 mg
D. Paxil Tablets 10 mg
The industrial methylated spirits used to manufacture paroxetine drug substance were contaminated with material from the pharmaceutical waste tank which contained various other APIs, intermediates and solvents. GSK is recalling all tablet lots which were manufactured with the contaminated paroxetine drug substance batches.
Wholesalers across Canada